Burning Rock Biotech Ltd (BNR) ADR Each Representing 10 Ord A Shares SPON
0.35%- This stock can be held in a
Create an alert
Stocks and Shares ISA
SIPP
$0.31
(5.07%)$0.31
(5.07%)Company Information
About this company
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Key people
Key facts
- EPICBNR
- LocationChina
- SectorHealthcare
- IndustryHealthcare Facilities
- ISINUS12233L2060
- Market cap$65.69m
- Employees674
- Shares in issue0.00
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.